RFG
JAZZ icon

RFP Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

RFP Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$241 – 919
2024
Q1 		$241 Hold
2
– – ﹤0.01% 831
2023
Q4 		$246 Hold
2
– – ﹤0.01% 856
2023
Q3 		$259 Hold
2
– – ﹤0.01% 877
2023
Q2 		$248 Buy
+2
New +$269 ﹤0.01% 922
2023
Q1 		– Sell
-2
Closed -$319 – 802
2022
Q4 		$319 Buy
+2
New +$293 ﹤0.01% 884

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

RFP Financial Group's JAZZ Position: Q2 2024 in Review

RFP Financial Group sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 2 shares — an estimated $241 sold.

RFP Financial Group first reported a position in JAZZ in Q4 2022 and held it in 5 quarters. The position peaked at $319 in Q4 2022. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • RFP Financial Group reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • RFP Financial Group sold 2 Jazz Pharmaceuticals shares in Q2 2024, an estimated $241.
  • RFP Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • RFP Financial Group's Jazz Pharmaceuticals position peaked at $319 in Q4 2022.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on RFP Financial Group's 13F filing for Q2 2024, filed 25 Jul 2024.